Lu-AF95245

N/A

Report date: 2024/12/05 10:51:44

NME

Base Information

Drug NameLu-AF95245

Drug Alias NameLu-AF95245

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 agonistsPotassium voltage-gated channel subfamily KQT member 3 activatorsPotassium voltage-gated channel subfamily KQT member 4 agonists +[4]

TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3Potassium voltage-gated channel subfamily KQT member 4 +[4]

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesH. Lundbeck A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesH. Lundbeck A/S

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A